Format

Send to

Choose Destination
JOP. 2012 Mar 10;13(2):131-4.

Early detection of pancreatic cancer.

Author information

1
Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY 10032, USA.

Abstract

Despite treatment advances pancreatic cancer remains one of the most lethal malignancies. It is expected that early detection and screening of high risk patient population may have the most significant impact on altering overall survival in this disease. Serologic biomarkers may be the most useful in early detection and histology-based markers may have the most significant role in differentiating benign, pre-malignant and malignant lesions. Here we review several serum and tissue-based biomarkers and summarize new data presented at the 2012 ASCO Gastrointestinal Cancers Symposium (Abstracts #151, #164, #188) on the potential role of PAM4 in pancreatic cancer screening and diagnosis.

PMID:
22406583
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for JOP. Journal of the Pancreas (Online)
Loading ...
Support Center